TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive In Brief: NCCS Honors 14 Who Make A Difference; Lasker Awards Presented To Seven Scientists October 2, 1998
TCL Archive Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion June 23, 1995